IMD business school for management and leadership courses

Novo Nordisk has made AI a central pillar of its digital transformation strategy, applying it across R&D, regulatory affairs, and internal operations. In January 2025, the company expanded its collaboration with Valo Health to apply AI and human data in developing treatments for obesity and type 2 diabetes.  

AI applications are being integrated into products and services, particularly in regulatory and scientific workflows to automate document summarization and compliance writing. In R&D, ontology-based data management systems are being deployed to federate research datasets and improve AI-driven discovery pipelines. Internally, the company has rolled out Microsoft Copilot to more than 20,000 employees, supported by a “champion network” and adaptive governance structures. Ethics and governance remain a priority. Novo Nordisk embeds AI and data ethics principles into its OneCode compliance framework, emphasizing autonomy, fairness, transparency, and accountability.